Individualizing Surveillance Mammography for Older Breast Cancer Survivors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03865654|
Recruitment Status : Active, not recruiting
First Posted : March 7, 2019
Last Update Posted : May 20, 2019
|Condition or disease||Intervention/treatment||Phase|
|Breast Cancer||Other: Communication Tool||Not Applicable|
The investigators will develop a communication tool that summarizes recommendations for clinicians and patients for surveillance mammography and follow-up care for breast cancer survivors age ≥75. Developing expert-panel recommendations, examining clinician and patient attitudes towards these recommendations, and testing a strategy for communication of expert recommendations on mammography cessation through direct engagement of specialists, primary care clinicians (PCs), and patients.
This is a multi-step study, the investigators will build on prior steps to develop consensus on surveillance mammography and follow-ups for breast cancer survivors who are age >= 75.
This study includes a physician focus group.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||45 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Individualizing Surveillance Mammography for Older Breast Cancer Survivors|
|Actual Study Start Date :||May 16, 2019|
|Estimated Primary Completion Date :||January 1, 2020|
|Estimated Study Completion Date :||January 1, 2021|
Experimental: Surveillance Mammography Communication Tool
Other: Communication Tool
Summarizes recommendations for clinicians and patients for surveillance mammography and follow-up care for breast cancer survivors
- Rate of change in intentions for mammography in the next year [ Time Frame: 2 years ]Survey measure on whether mammography will be done or not
- Rate of satisfaction [ Time Frame: 2 years ]Survey asking about satisfaction with the tool
- Preferred decision-making role [ Time Frame: 2 years ]Survey on preferred decision-making style
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03865654
|United States, Massachusetts|
|Dana-Farber Cancer Institute|
|Boston, Massachusetts, United States, 02215|
|Principal Investigator:||Rachel Freedman, MD, MPH||Dana-Farber Cancer Institute|